Results 251 to 260 of about 166,379,765 (297)
Some of the next articles are maybe not open access.
PharmacoEconomics, 2006
The number of cost-of-illness (COI) studies has expanded considerably over time. One outcome of this growth is that the reported COI estimates are inconsistent across studies, thereby raising concerns over the validity of the estimates and methods.
Ebere, Akobundu +3 more
openaire +2 more sources
The number of cost-of-illness (COI) studies has expanded considerably over time. One outcome of this growth is that the reported COI estimates are inconsistent across studies, thereby raising concerns over the validity of the estimates and methods.
Ebere, Akobundu +3 more
openaire +2 more sources
PharmacoEconomics, 2009
Cost-of-illness studies determine the total financial burden of a disease by considering direct and indirect costs, including medication, diagnostics and surgery. Studies of resource use and costs associated with primary open-angle glaucoma have used varying methodologies.
Richard G, Fiscella +3 more
openaire +2 more sources
Cost-of-illness studies determine the total financial burden of a disease by considering direct and indirect costs, including medication, diagnostics and surgery. Studies of resource use and costs associated with primary open-angle glaucoma have used varying methodologies.
Richard G, Fiscella +3 more
openaire +2 more sources
PharmacoEconomics, 2011
Cost-of-illness (COI) studies aim to assess the economic burden of health problems on the population overall, and they are conducted for an ever widening range of health conditions and geographical settings. While they attract much interest from public health advocates and healthcare policy makers, inconsistencies in the way in which they are conducted
Larg, A., Moss, J.
openaire +3 more sources
Cost-of-illness (COI) studies aim to assess the economic burden of health problems on the population overall, and they are conducted for an ever widening range of health conditions and geographical settings. While they attract much interest from public health advocates and healthcare policy makers, inconsistencies in the way in which they are conducted
Larg, A., Moss, J.
openaire +3 more sources
Theoretical considerations on the cost of illness
Journal of Health Economics, 1983This paper explores the measurement of the cost of illness from a theoretical perspective. It is shown that under a wide range of circumstances the aggregate willingness to pay ex ante to reduce the probability of an illness exceeds (1) the consumer surplus gained ex post from such a reduction, and also (2) the sum of medical expenditure saved and ...
openaire +2 more sources
Estimating the Direct Costs of Illness
The Milbank Memorial Fund Quarterly. Health and Society, 1982about estimating the costs of illness has centered around the relative advantages and disadvantages of the two basic methodologies used or proposed-the "human capital" method as against "willingness to pay." Very briefly, the human capital approach requires estimating the direct costs of illness, i.e., the costs of prevention, detection, treatment, and
openaire +2 more sources
Nederlands tijdschrift voor geneeskunde, 1992
This study is an essential prerequisite to gain more insight into the complex relationship between public health and the costs of medical care. It offers a first tentative but comprehensive description of the total direct costs generated by all diseases in the Dutch population.
L, van Roijen +2 more
openaire +1 more source
This study is an essential prerequisite to gain more insight into the complex relationship between public health and the costs of medical care. It offers a first tentative but comprehensive description of the total direct costs generated by all diseases in the Dutch population.
L, van Roijen +2 more
openaire +1 more source
PharmacoEconomics, 1998
A sample of cost-of-illness (COI) studies was reviewed, which included studies for specific diseases ('specific' studies) as well as those for the entire range of diseases ('general' studies). Theoretically, COI studies may deliver suitable information for health policy and rational healthcare spending.
openaire +4 more sources
A sample of cost-of-illness (COI) studies was reviewed, which included studies for specific diseases ('specific' studies) as well as those for the entire range of diseases ('general' studies). Theoretically, COI studies may deliver suitable information for health policy and rational healthcare spending.
openaire +4 more sources
Problems in Measuring the Cost of Illness
Evaluation & the Health Professions, 1982Cost of illness (COI) studies have grown in importance in the last decade. They are frequently used in funding decisions for selected health care programs. Cost of illness study proponents present their results as objective, unbiased analysis. Yet, there are severe conceptual and methodological difficulties with the technique.
openaire +2 more sources
Cost of illness due to dementia in Sweden
International Journal of Geriatric Psychiatry, 1997The gross cost of illness due to dementia was estimated to be SEK30.7 billion in 1991 while the net cost was estimated to be SEK20 billion. The sensitivity analysis showed a variation between SEK20 billion and SEK36 billion in 1991.
A, Wimo +4 more
exaly +3 more sources